Important note

This AI stock analysis for Clover Health is not up to date. Creating and accessing our AI stock Analysis (powered by our data and Chat GPT) is only available for our premium users. Sign up to get access today!

Clover Health - AI Stock Analysis

Analysis generated July 7, 2024

Clover Health (CLOV), founded in 2014 and headquartered in Nashville, Tennessee, operates as a next-generation Medicare Advantage insurer leveraging technology and data analytics to provide value-based healthcare. Clover Health's platform, Clover Assistant, aims to enhance the quality of care for patients while optimizing healthcare expenditures. Despite facing challenges, including regulatory scrutiny and competitive pressures, Clover continues to emphasize innovation and expansion within the Medicare market.

Fundamental Analysis

Clover Health's financial performance offers a mixed picture. Revenue for the last quarter was $347 million. This represents a decrease of 32.01% compared to the previous quarter, signaling a need for concern. However, on a year-over-year basis, there is an increase of 7.74%, indicating a positive trend in long-term growth.

Net income for the last quarter was $19 million, marking a robust 72.80% increase compared to the prior quarter. Year-over-year, net income surged by 73.60%, demonstrating strong profitability improvements.

EBITDA for the last quarter was $22 million, reflecting an increase of 65.55% compared to the previous quarter. Year-over-year, EBITDA showed a gain of 69.05%, suggesting significant operational performance improvements.

Technical Analysis

Today's stock price of Clover Health is $1.27, representing an increase of 15.45% compared to a month ago, indicating a positive short-term trend. Year-over-year, the stock price has increased by 53.01%, suggesting a strong long-term trend. However, it is crucial to note that the current trend remains bearish.

The current SMA10 is $1.24, slightly lower than the previous SMA10 of $1.25, indicating a potential downward trend in price movement. The Relative Strength Index (RSI) is 94.7, indicating an overbought condition, which is typically a bearish signal.

Alternative Data Analysis

Examining alternative data, Clover Health shows promising signs. The company has 23 open positions, an increase of 53% in the last couple of months, suggesting growth and expansion intentions. The business outlook has improved by 10%, a positive trend.

Visitor engagement on Clover Health's webpage is up by 71% with an estimated 210,000 visitors, indicating a potential increase in customer acquisition. On the downside, Twitter followers have decreased by 1% in the last couple of months, signifying a slight loss in interest.

The AltIndex AI score is 65, indicating a "buy" signal based on a combination of fundamental, technical, and alternative data analysis.

Conclusion and Recommendation

From the various analyses, Clover Health appears to be a company with substantial potential but also significant risks. The fundamental analysis reveals mixed signals, with a recent quarter-over-quarter revenue decline but notable year-over-year growth in revenue, net income, and EBITDA. The technical analysis suggests a bearish connotation despite short-term price increases, as reflected by the SMA10 and RSI values. The alternative data analysis portrays an expanding company with increased job postings and visitor engagement, even though social media engagement dipped slightly.

Given the combined data, the indications of growth and fundamental improvements outweigh the short-term technical concerns. Therefore, influenced by the AltIndex AI score of 65, I recommend a cautious "buy" for investors willing to embrace some risk for potential long-term gains.

Disclaimer: This AI stock analysis, generated by an experimental AI tool, is for informational purposes only and not financial advice. Information is based on publicly available data and may not always be accurate or current.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.